Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

ViaNautis Bio received an undisclosed funding amount from SCI Ventures to expand its central nervous system portfolio.

PRIVATESep 09, 2026•about 2 hours ago

Round Type

Venture - Series Unknown

CambridgeBiotechnologyHealth Care

Investors

Sci Ventures

Description

ViaNautis Bio, a Cambridge-based provider of tPNVs for genetic medicines, has secured investment from SCI Ventures. The amount of the deal was not disclosed. The company intends to use the funds to expand its CNS portfolio into chronic spinal cord injury. With its innovative delivery platform, it aims to advance pipelines in multiple diseases.

Company Information

Company

ViaNautis

Location

Cambridge, Massachusetts, United States

About

ViaNautis, formerly known as SomaServe, was founded in 2018 as a spin-off from UCL under the leadership of CEO and serial entrepreneur, Dr Francesca Crawford. The company’s core mission is to exploit the unique capabilities of the revolutionary polyNaut® technology.

Don't miss ViaNautis's next move

Get an email the moment ViaNautis raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ViaNautis's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

ViaNautis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.